We are delighted to welcome Professor Celia Berkers to the Molecular Omics Editorial Board!
Celia Berkers is Professor of Metabolomics at Utrecht University (the Netherlands). She started her PhD at Harvard Medical School (Boston) before moving to the Netherlands Cancer Institute (Amsterdam) where she completed it in 2010. Berkers did her post-doctoral research in the laboratory of Professor Karen Vousden at the Beatson Institute for Cancer Research (Glasgow). She joined the Biomolecular Mass Spectrometry and Proteomics Group at Utrecht University in 2013 as an independent group leader in Metabolomics and was appointed full Professor in 2018. She is currently affiliated with both the Division Cell Biology, Metabolism & Cancer at the Faculty of Veterinary Medicine and the Biomolecular Mass spectrometry and Proteomics Group in the Faculty of Science.
The Berkers group develops and applies metabolomics and fluxomics tools to advance our understanding of the (re)wiring of metabolism in health and disease. Her team combines these metabolomics methodologies with advanced in-vitro model systems and cross-omics data analysis, with the ultimate goal of identifying novel metabolic targets that can be exploited for therapy. The team’s research currently focuses on applications in cancer- and immuno-metabolism.
Find out more on Celia’s group webpage and check out some of her RSC publications below.
Targeting coenzyme Q10 synthesis overcomes bortezomib resistance in multiple myeloma
Esther A. Zaal, Harm-Jan de Grooth, Inge Oudaert, Pieter Langerhorst, Sophie Levantovsky, Gijs J. J. van Slobbe, Jeroen W. A. Jansen, Eline Menu, Wei Wu and Celia R. Berkers
Mol. Omics, 2022, 18, 19-30
Find out more about our full Editorial Board on our webpage.